Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16063 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N59-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
filingDate |
2009-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102036567-B1 |
titleOfInvention |
Anti-viral agent |
abstract |
An object of the present invention is to provide an antiviral agent capable of inactivating various viruses and a product having the antiviral agent. In order to achieve this object, the present invention provides an antiviral agent comprising at least one type of iodide or at least one type of iodide composed of iodine and elements described in Groups 8 to 15, which are periods 4 to 6 of the periodic table. It is characterized by containing a copper compound as an active ingredient or effective ingredients. The antiviral agent of the present invention has a higher degree of freedom in designing the constituents than the conventional antiviral agent. Moreover, since the said anti-irritant can be manufactured without requiring any pretreatment or a special washing process, antiviral expression and maintenance are easy. |
priorityDate |
2008-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |